Author:
Masoumi Mohammadreza,Ebadi Fard Azar Farbod,RezaPour Aziz,Mehrara Mohsen
Abstract
Abstract
Background
The pharmaceutical industry in Iran is influenced by various parameters such as internal factors caused by the financial information of each economic unit and external factors including major economic and non-economic variables.
Methods
This study is aiming to examine the effect of such variables on the stock return of 34 pharmaceutical companies in the Tehran Securities Exchange market using quarterly data from 1995 to 2016. In this research, an autoregressive model was utilized to examine the way that variables affect the stock market index. In such patterns, there is no need for explicit short-term structural relationships and structural knowledge is extracted from causal relationships. Finally, to analyze the results, impulse-response functions, forecast error variance, and historical decomposition were collected.
Results
Results of this research show that positive shock to the variables, namely the currency rate, collection period of quests, and healthcare costs lead to a decrease in the return of pharmaceutical companies. On the other hand, a positive shock to the variables such as GDP, and money volume, leads to an increase in the stock return of pharmaceutical companies.
Conclusion
Different factors contribute to the stock return of pharmaceutical companies. Among the variables examined in this study, market currency rate, money volume, pharmaceutical sector inflation, bank interest rate, GDP in the healthcare sector, healthcare costs, and collection period of quests have the most effect on describing changes within the stock return of pharmaceutical companies.
Funder
Iran University of Medical Sciences
Publisher
Springer Science and Business Media LLC
Reference44 articles.
1. Pharmaceutical market volume. Available from www.imshealth.com. Accessed 1 Dec 2014.
2. Pharmaceutical industry Iran, current status, opportunities and threat. Available from http://www.ilia-corporation.com/insights/white-papers/pharmaceutical-industry-iran. Accessed 1 Mar 2014.
3. Cheraghali AM. Trends in Iran pharmaceutical market. Iranina J Pharm Res. 2017;16(1):1–7.
4. Karampli E, Souliotis K, Polyzos N, Kyriopulos J, Chatzaki E. Pharmaceutical innovation: impact on expenditure and outcomes and subsequent challenges for pharmaceutical policy, with a special reference to Greece. Hippokratia. 2014;18(2):100–6.
5. Tehran Securities stock market data. Available from www.tsetmc.com. Accessed 20 Dec 2013.
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献